Medicare Will Pay for Pricey Prostate Cancer Drug (HealthDay)

HealthDay - THURSDAY, June 30 (HealthDay News) -- The cost of Provenge, an
expensive and newly approved therapeutic prostate cancer vaccine, will be
covered by Medicare for men with metastatic prostate cancer, the agency
announced late Thursday.

Source: http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/hsn/20110701/hl_hsn/medicarewillpayforpriceyprostatecancerdrug

diet health food